Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arbios struggling to stave off liquidation

This article was originally published in Clinica

Executive Summary

Liver failure specialist Arbios Systems could be less than a month away from liquidation after it shutdown its day-to-day operations and released the main bulk of its workforce in order to preserve cash. The Waltham, Massachusetts company is looking to obtain financing or enter a strategic transaction to fund clinical trials for its Sepet liver assist device, and submit FDA and CE-mark applications for the product. President and CEO Shawn Cain and CFO Scott Hayashi have retained their positions at Arbios but in a part-time capacity. The company has until August 31 to secure additional financing, or it will have to consider potential liquidation. Mr Cain said that Arbios had been searching for new funds for several months and had been so far unsuccessful.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043235

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel